Confined or spread disease-Confined to the prostate gland - Page 11 of 13 Posts on Medivizor
Navigation Menu

Confined or spread disease-Confined to the prostate gland Posts on Medivizor

The effects of non-metastatic prostate cancer treatment on urinary functions

Posted by on Jan 26, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effect of radiation and surgery on urinary adverse effects in prostate cancer. Some background Prostate cancer is usually treated with surgery or radiation with high rates of long-term survival. Surgery can involve procedures such as a radical prostatectomy which involves removing the entire...

Read More

Reviewing the cardicovascular effects of androgen deprivation therapy in prostate cancer

Reviewing the cardicovascular effects of androgen deprivation therapy in prostate cancer

Posted by on Jan 19, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether patients who received androgen deprivation therapy were more at risk of experiencing cardiovascular events. Some background Androgen deprivation therapy (ADT) is a hormone treatment that targets male sex hormones involved in prostate cancer development, such as testosterone, in early stage...

Read More

Can PSA level indicate either cure or the need for long term hormone suppression treatment?

Can PSA level indicate either cure or the need for long term hormone suppression treatment?

Posted by on Jan 12, 2015 in Prostate cancer | 1 comment

In a nutshell This study investigated if measuring the levels of prostate specific antigen (PSA) after cancer therapy could indicate a cure or if the patient should be considered for long term androgen deprivation (suppression) therapy. The main finding was that lower PSA blood levels predict better survival in patients with prostate cancer. Some...

Read More

NADiA ProsVue – accurate predictor of prostate cancer recurrence in radical prostatectomy patients

NADiA ProsVue – accurate predictor of prostate cancer recurrence in radical prostatectomy patients

Posted by on Dec 16, 2014 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether their product could be used to determine prostate cancer-specific mortality and other outcomes after radical prostatectomy. Some background NADiA ProsVue is a device that determines the likelihood that a prostate cancer patient will experience recurrent cancer after receiving a radical...

Read More

Does hypofractionated radiotherapy have better or worse erectile function outcomes compared to conventional therapy?

Does hypofractionated radiotherapy have better or worse erectile function outcomes compared to conventional therapy?

Posted by on Dec 15, 2014 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether moderate hypofractionated radiotherapy would worsen sexual function after treatment. Some background There are many options for treatment of low-risk prostate cancer (cancer with a very small likelihood of spreading), therefore side-effects and patient preferences may drive the decision of...

Read More

How should biochemical recurrence be defined after external beam radiation therapy?

Posted by on Jun 28, 2014 in Prostate cancer | 0 comments

In a nutshell The authors aimed to evaluate if a new definition of biochemical recurrence is appropriate in prostate cancer treated with radical external beam radiation. Some background Prostate-specific antigen is a protein that is found at higher levels in the blood when prostate cancer is present. After prostatectomy (surgery to remove the...

Read More

Prediction of toxicity and quality of life for patients undergoing intensity modulated radiotherapy

Prediction of toxicity and quality of life for patients undergoing intensity modulated radiotherapy

Posted by on May 25, 2014 in Prostate cancer | 0 comments

In a nutshell The study determined the incidence of genitourinary toxicity and the quality of life in patients after intensity-modulated radiotherapy. Some background Patients with localized prostate cancer (cancer that has not spread) may be treated using a high-energy radiation that kills cancer cells (radiotherapy). Application of radiotherapy...

Read More